Back to Agenda
Session 8: Ask the Regulators
Session Chair(s)
Steven B. Binion
Director, Policy, Technology, and Communication - Corporate Regulatory Affairs
Becton Dickinson, United States
Join this final session of the conference for a unique chance to meet with senior FDA leaders and ask questions regarding current issues and opportunities in the regulation of combination products in an open and interactive session.
Speaker(s)
Panelists
Elizabeth Baker
Medicines and Healthcare Products Regulatory Agency (MRHA), United Kingdom
Group Manager Licensing Division
Patricia Love, MD, MBA
FDA, United States
Deputy Director, Office of Combination Products, OCPP, OC
William H. Maisel, MD, MPH
FDA , United States
Deputy Director for Science and Chief Scientist, Director, ODE (Acting), CDRH
Diane Maloney, JD
FDA, United States
Associate Director for Policy, CBER
Thinh X. Nguyen
FDA, United States
Director, Office of Combination Products, OCPP
Douglas C. Throckmorton, MD
FDA, United States
Deputy Center Director for Regulatory Programs CDER
John Weiner, JD
FDA, United States
Associate Director for Policy, Office of Combination Products, OCPP, OC
Have an account?